Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease.

Authors

Stewart F. Graham, Beaumont Health
Zafer Ugur, Beaumont Health
Ali Yilmaz, Beaumont Health
Michael Maddens, Beaumont Health
Ray O. Bahado-Singh, Beaumont Health

Document Type

Article

Publication Date

10-31-2018

Abstract

For people with Parkinson's disease (PD), considered the most common neurodegenerative disease behind Alzheimer's disease, accurate diagnosis is dependent on many factors; however, misdiagnosis is extremely common in the prodromal phases of the disease, when treatment is thought to be most effective. Currently, there are no robust biomarkers that aid in the early diagnosis of PD. Following previously reported work by our group, we accurately measured the concentrations of 18 bile acids in the serum of a prodromal mouse model of PD. We identified three bile acids at significantly different concentrations (

Volume

8

Issue

4

Recommended Citation

Graham SF, Rey NL, Ugur Z, Yilmaz A, Sherman E, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P. Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease. Metabolites. 2018 Oct 31;8(4). doi: 10.3390/metabo8040071. PubMed PMID: 30384419; PubMed Central PMCID: PMC6316593.

ISSN

2218-1989

PubMed ID

30384419